Radicava ORS
Total Payments
$18,824
Transactions
6
Doctors
6
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $3,850 | 1 | 1 |
| 2022 | $14,974 | 5 | 5 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,954 | 4 | 79.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,850 | 1 | 20.5% |
| Food and Beverage | $20.15 | 1 | 0.1% |
Top Doctors Receiving Payments for Radicava ORS
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Clinical Neurophysiology | Loma Linda, CA | $5,500 | 1 |
| , M.D | Neuromuscular Medicine | Chattanooga, TN | $4,240 | 1 |
| , MD | Clinical Neurophysiology | Saint Louis, MO | $3,850 | 1 |
| , MD | Neurology | Seattle, WA | $3,850 | 1 |
| , MD, PHD | Neuromuscular Medicine | Chicago, IL | $1,364 | 1 |
| , MD | Neurology | Cordova, TN | $20.15 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $18,824
- Total Doctors 6
- Transactions 6
About Radicava ORS
Radicava ORS is a drug associated with $18,824 in payments to 6 healthcare providers, recorded across 6 transactions in the CMS Open Payments database. The primary manufacturer is MITSUBISHI TANABE PHARMA AMERICA, INC..
Payment data is available from 2022 to 2023. In 2023, $3,850 was paid across 1 transactions to 1 doctors.
The most common payment nature for Radicava ORS is "Consulting Fee" ($14,954, 79.4% of total).